Diaceutics (LON:DXRX) Trading Up 0.4%

Diaceutics PLC (LON:DXRX)’s stock price was up 0.4% during mid-day trading on Thursday . The stock traded as high as GBX 122 ($1.55) and last traded at GBX 120.50 ($1.53). Approximately 53,456 shares changed hands during trading, a decline of 51% from the average daily volume of 108,730 shares. The stock had previously closed at GBX 120 ($1.52).

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group reiterated a “buy” rating and set a GBX 150 ($1.90) price objective on shares of Diaceutics in a research report on Tuesday, May 21st.

Diaceutics Trading Up 6.2 %

The stock has a market cap of £108.07 million, a PE ratio of 10,500.00 and a beta of 0.47. The business has a 50-day moving average of GBX 116.12 and a 200 day moving average of GBX 103.51. The company has a debt-to-equity ratio of 3.07, a quick ratio of 9.92 and a current ratio of 7.99.

Insider Buying and Selling

In other Diaceutics news, insider Graham Paterson purchased 39,934 shares of the stock in a transaction on Wednesday, May 22nd. The stock was bought at an average price of GBX 129 ($1.64) per share, for a total transaction of £51,514.86 ($65,349.31). 34.54% of the stock is currently owned by company insiders.

About Diaceutics

Diaceutics PLC, a diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics.